Live Breaking News & Updates on Restoring exclusivity

Healthcare Roundup: May 11, 2023 - Healthcare

Senate Health, Education, Labor, and Pensions (HELP) Committee marked up and approved several drug-pricing legislation, including the Pharmacy Benefit Manager Reform Act.

Washington , United-states , New-york , Americans , America , Susan-collins , Debbie-stabenow , Tina-smith , National-institutes-of-health , Public-health , Human-service , Government-accountability-office

Washington Healthcare Update - May 2023 #2 | McGuireWoods Consulting

This Week in Washington: Debt Ceiling Continues to Loom Over the Capitol; DEA Extends COVID-19 Controlled Medications Prescribing Telehealth Flexibilities.

United-states , Longworth-house-office-building , District-of-columbia , Texas , Washington , Dirksen-senate-office-building , Americans , David-herman , William-morris , Tony-gonzales , Bradw-setser , Darius-lakdawalla

Washington Healthcare Update - May 2023 | McGuireWoods Consulting

This Week in Washington: Debt Limit fight continues; Disagreements arise during Senate HELP Committee mark-up of PBM and Generic Drug Competition Bills.

Dirksen-senate-office-building , District-of-columbia , United-states , Texas , Manhattan , New-york , Longworth-house-office-building , White-house , Wisconsin , Rayburn-house-office-building , Hart-senate-office-building , China

Executive and Legislative Healthcare Updates May 9 2023

Biden will meet House Speaker Kevin McCarthy, House Minority Leader Hakeem Jeffries, Senate Majority Leader Chuck Schumer, Senate Minority Leader Mitch McConnell at White House to discuss debt ceiling. There are few days for House and Senate to agree before June 1 default.

White-house , District-of-columbia , United-states , Kevin-mccarthy , Hakeem-jeffries , Drug-administration , House-ways-means-health-subcommittee , Centers-for-disease , Senate-health , Senate-majority-leader-chuck-schumer , Congressional-budget-office , Medicaid-services-or-congress

FDA Doubles Down on Its Pre-Catalyst Stance on Orphan Drug Exclusivity | Cooley LLP

On January 24, 2023, the Food and Drug Administration published a notice in the Federal Register to “address the uncertainty” created by the US Court of Appeals for the Eleventh.

United-states , Jacobus-pharmaceutical-co , Catalyst-pharms-inc , Chevron , Drug-administration , Us-court , Office-of-orphan-products-development , Federal-register , Eleventh-circuit , Catalyst-pharms , Jacobus-pharmaceutical

NORD Applauds Legislative Efforts to Restore Intent of the Orphan Drug Act

/PRNewswire/ The National Organization for Rare Disorders (NORD) applauds efforts of Congressional leaders to protect the Orphan Drug Act (ODA) and ensure.

United-states , Washington , Americans , Peterl-saltonstall , Heidi-ross , National-organization-for-rare-disorders , Catalyst-pharms-inc , Regulatory-affairs , Commerce-committee , House-energy , National-organization , Rare-disorders